Most cited article - PubMed ID 35470385
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2
Blood advances.
2022 Oct 11 ;
6 (19) :
5550-5555.
Blood cancer journal.
2025 Aug 01 ;
15 (1) :
129.
[epub] 20250801
ClinicalTrials.gov number: NCT01777152.
- MeSH
- Lymphoma, Large-Cell, Anaplastic * drug therapy mortality pathology MeSH
- Brentuximab Vedotin * administration & dosage therapeutic use adverse effects MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Follow-Up Studies MeSH
- Antineoplastic Combined Chemotherapy Protocols * therapeutic use adverse effects MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial, Phase III MeSH
- Multicenter Study MeSH
- Randomized Controlled Trial MeSH
- Names of Substances
- Brentuximab Vedotin * MeSH
